Inflammation of the gastrointestinal tract is a complex biological response to harm caused by bacteria, damaged cells, or irritants. The symbiotic microbiome in the digestive tract is thought to protect the gut by eliminating unwanted stimuli and promoting recovery. The presence or lack of a microbiome can cause type 2 immunity to be worsened, as well as allergic/infectious and inflammatory consequences, including parasitic diseases. Inflammation of the gastrointestinal tract is frequently accompanied by changes in vascular anatomy and function. Microvascular congestion, Dilatation of the arteries supplying the tissue, and excessive fluid and protein leakage with interstitial oedema are examples of these disorders. IBD medications can often reduce inflammation and improve intestinal healing, leading in remission—long-term symptom relief. Many persons with IBD, however, have a chronic illness that requires lifelong therapy.
Title : Early and late evaluation of esophageal mucosectomy in surgical treatment of advanced esophageal achalasia
Jose Luis Braga De Aquino, Pontifical Catholic University of Campinas, Brazil
Title : How epigastric impedance would radically change gastric medicine
John Andrew Sutton, Invention City, United States
Title : Nanoemulsions as a strategy to enhance gastrointestinal bioavailability and bioactivity of lipid based nutraceuticals
Pubali Dhar, University of Calcutta, India
Title : Professional dining and health
Yaffa Machnes, Bar-Ilan University, Israel
Title : Sickle cell liver disease: A multidisciplinary hemato-hepatology approach
Bandar Aljudaibi, King Faisal Specialists Hospital and Research Centre, Saudi Arabia
Title : From the birth of atoms to life: Iodine and caesium, angels and demons of evolutionary biology, in pancreatic cancer and diabetes
Venturi Sebastiano, Department of Public Health of Romagna, Italy